128 related articles for article (PubMed ID: 4631999)
1. Mutagenicity of primary and secondary carcinogens altered by normal and induced hepatic microsomes.
Popper H; Czygan P; Greim H; Schaffner F; Garro AJ
Proc Soc Exp Biol Med; 1973 Feb; 142(2):727-9. PubMed ID: 4631999
[No Abstract] [Full Text] [Related]
2. The effect of dietary protein deficiency on the ability of isolated hepatic microsomes to alter the mutagenicity of a primary and a secondary carcinogen.
Czygan P; Greim H; Garro A; Schaffner F; Popper H
Cancer Res; 1974 Jan; 34(1):119-23. PubMed ID: 4588542
[No Abstract] [Full Text] [Related]
3. Microsomal metabolism of dimethylnitrosamine and the cytochrome P-450 dependency of its activation to a mutagen.
Czygan P; Greim H; Garro AJ; Hutterer F; Schaffner F; Popper H; Rosenthal O; Cooper DY
Cancer Res; 1973 Nov; 33(11):2983-6. PubMed ID: 4201248
[No Abstract] [Full Text] [Related]
4. Cytochrome P-450 content and the ability of liver microsomes from patients undergoing abdominal surgery to alter the mutagenicity of a primary and secondary carcinogen.
Czygan P; Greim H; Garro AJ; Hutterer F; Rudick J; Schaffner F; Popper H
J Natl Cancer Inst; 1973 Dec; 51(6):1761-4. PubMed ID: 4587754
[No Abstract] [Full Text] [Related]
5. Immunochemical study on the role of different types of microsomal cytochrome P-450 in mutagenesis by chemical carcinogens.
Kawajiri K; Yonekawa H; Harada N; Noshiro M; Omura T; Tagashira Y
Cancer Res; 1980 May; 40(5):1652-7. PubMed ID: 6768451
[No Abstract] [Full Text] [Related]
6. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
Ishii K; Maeda K; Kamataki T; Kato R
Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of emodin in the reconstituted cytochrome P-450 system of the hepatic microsomes of rats.
Tanaka H; Morooka N; Haraikawa K; Ueno Y
Mutat Res; 1987 Feb; 176(2):165-70. PubMed ID: 3100945
[TBL] [Abstract][Full Text] [Related]
8. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
Guobaitis RJ; Ellingham TJ; Maddock MB
Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
[TBL] [Abstract][Full Text] [Related]
9. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity and rat-liver S9 demethylation kinetics of N-nitrosomethylaniline and its ring-substituted derivatives.
Kroeger-Koepke MB; Andrews AW; Kupper RJ; Koepke SR; Michejda CJ
Mutat Res; 1981 Aug; 89(4):255-67. PubMed ID: 7027031
[TBL] [Abstract][Full Text] [Related]
11. Metabolic alpha-hydroxylation of the tobacco-specific carcinogen, N'-nitrosonornicotine.
Chen CB; Hecht SS; Hoffmann D
Cancer Res; 1978 Nov; 38(11 Pt 1):3639-45. PubMed ID: 359127
[No Abstract] [Full Text] [Related]
12. Immunological analysis of the roles of two major types of cytochrome P-450 in mutagenesis of compounds isolated from pyrolysates.
Watanabe J; Kawajiri K; Yonekawa H; Nagao M; Tagashira Y
Biochem Biophys Res Commun; 1982 Jan; 104(1):193-9. PubMed ID: 6803780
[No Abstract] [Full Text] [Related]
13. Specificity of hepatic cytochrome P-450 isoenzymes from PCB-treated rats and participation of cytochrome b5 in the activation of aflatoxin B1.
Ueno Y; Ishii K; Omata Y; Kamataki T; Kato R
Carcinogenesis; 1983 Aug; 4(8):1071-3. PubMed ID: 6409444
[TBL] [Abstract][Full Text] [Related]
14. Metabolic activation of chemical carcinogens by hepatic preparations from streptozotocin-treated rats.
Flatt PR; Bass SL; Ayrton AD; Trinick J; Ioannides C
Diabetologia; 1989 Feb; 32(2):135-9. PubMed ID: 2524416
[TBL] [Abstract][Full Text] [Related]
15. [Activity of enzymes of xenobiotic metabolism in the liver of rats after administration of polychlorinated biphenyls].
Tutel'ian VA; Lashneva NV; Sorokovaia GK; Kravchenko LV; Chichilanova GV; Ivanenko GF; Gadzhieva ZM
Gig Sanit; 1990 May; (5):20-3. PubMed ID: 2118877
[No Abstract] [Full Text] [Related]
16. [Sovol as an inducer of procarcinogen activating microsomal enzymes].
Belitskiĭ GA; Fonshteĭn LM; Khudoleĭ VV; Demakov VA; Kiseleva MG
Eksp Onkol; 1987; 9(3):20-3. PubMed ID: 3111822
[TBL] [Abstract][Full Text] [Related]
17. Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes to the metabolic activation of various chemical carcinogens.
Kawajiri K; Yonekawa H; Gotoh O; Watanabe J; Igarashi S; Tagashira Y
Cancer Res; 1983 Feb; 43(2):819-23. PubMed ID: 6401224
[No Abstract] [Full Text] [Related]
18. Influence of microsomal and cytosolic fractions from the liver of 4 animal species and man on the mutagenicity of carcinogenic aminoazo dyes and nature of the mutagenicity-enhancing factor in the cytosol from rat liver.
Mori Y; Niwa T; Yamazaki H; Ni-i H; Toyoshi K; Hirano K; Sugiura M
Chem Pharm Bull (Tokyo); 1984 Sep; 32(9):3641-50. PubMed ID: 6441646
[No Abstract] [Full Text] [Related]
19. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
[TBL] [Abstract][Full Text] [Related]
20. Effects of cytochrome p-448 and p-450 inducers on microsomal dimethylnitrosamine demethylase activity and the capacity of isolated microsomes to activate dimethylnitrosamine to a mutagen.
Guttenplan JB; Hutterer F; Garro AJ
Mutat Res; 1976 Jun; 35(3):415-22. PubMed ID: 778603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
